Basit öğe kaydını göster

dc.contributor.authorKoyuncu, Adem
dc.contributor.authorKoksal, Deniz
dc.contributor.authorOzmen, Ozlem
dc.contributor.authorDemirag, Funda
dc.contributor.authorBayiz, Hulya
dc.contributor.authorAydogdu, Koray
dc.contributor.authorBerkoglu, Mine
dc.date.accessioned2019-12-10T10:54:48Z
dc.date.available2019-12-10T10:54:48Z
dc.date.issued2015
dc.identifier.issn0973-1482
dc.identifier.urihttps://doi.org/10.4103/0973-1482.138094
dc.identifier.urihttp://hdl.handle.net/11655/14691
dc.description.abstractAim: Malignant pleural mesothelioma (MPM) is an aggressive tumor with poor prognosis. The study aims to examine the effect of certain clinical, laboratory, radiologic, and pathologic characteristics on survival. Patients and Methods: Sixty patients who had undergone PET/CT evaluation at initial diagnosis were included. We investigated the effect of certain clinical, laboratory, radiologic characteristics, SUVmax of the tumor, and pathological characteristics such as histological subtype, mitotic activity index (MAI), tumor necrosis, and inflammation on survival. The pathological slides of each patient were re-evaluated for MAI, presence of necrosis, and inflammation. The patients were grouped based on number of mitosis as MAI 1:<= 9, MAI 2: 10-19, MAI 3: > 19 mitosis. Results: There were 34 male and 26 female patients with a mean age of 53.6 +/- 10.6 years. Mean and median survival time was 14.83 +/- 10.75 and 11.95 (min 0.43-max 48.10) months, respectively. Using univariate analysis leukocytosis (P = 0.009), rind-like pleural thickening (P = 0.037), advanced disease stage (P = 0.004), best supportive therapy alone (P = 0.004), SUVmax higher than 8 (P = 0.023), MAI higher than 1 (P = 0.033), and presence of tumor necrosis (P = 0.037) were found as poor prognostic factors. At multivariate analysis, leukocytosis (P = 0.026, HR: 2.27), advanced disease stage (P = 0.021, HR: 2.46), best supportive therapy alone (P = 0.029, HR: 5.12), and MAI higher than 1 (P = 0.01, HR: 3.01) were independently associated with survival, whereas SUVmax of the tumor failed to enter the model (P = 0.07, HR: 1.89). Conclusion: Presence of leukocytosis, advanced disease stages, supportive therapy alone, and higher MAI were found to be negative prognostic factors in patients with MPM.
dc.language.isoen
dc.publisherWolters Kluwer Medknow Publications
dc.relation.isversionof10.4103/0973-1482.138094
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectOncology
dc.titlePrognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Study of 60 Turkish Patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal Of Cancer Research And Therapeutics
dc.contributor.departmentGöğüs Hastalıkları
dc.identifier.volume11
dc.identifier.issue1
dc.identifier.startpage216
dc.identifier.endpage222
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster